Compounds > erlotinib hydrochloride
Page last updated: 2024-09-05

erlotinib hydrochloride and transferrin

erlotinib hydrochloride has been researched along with transferrin in 3 studies

Compound Research Comparison

Studies
(erlotinib hydrochloride)		Trials
(erlotinib hydrochloride)		Recent Studies (post-2010)
(erlotinib hydrochloride)		Studies
(transferrin)		Trials
(transferrin)		Recent Studies (post-2010) (transferrin)
4,3537863,03317,5965543,141

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Lakkadwala, S; Singh, J1
Dos Santos Rodrigues, B; Lakkadwala, S; Singh, J; Sun, C2

Other Studies

3 other study(ies) available for erlotinib hydrochloride and transferrin

ArticleYear
Co-delivery of doxorubicin and erlotinib through liposomal nanoparticles for glioblastoma tumor regression using an in vitro brain tumor model.
    Colloids and surfaces. B, Biointerfaces, 2019, Jan-01, Volume: 173

    Topics: Antineoplastic Agents; Apoptosis; Biological Transport; Blood-Brain Barrier; Brain; Brain Neoplasms; Cell Line, Tumor; Cell-Penetrating Peptides; Chitosan; Doxorubicin; Drug Delivery Systems; Endothelial Cells; Erlotinib Hydrochloride; Glioblastoma; Humans; Liposomes; Models, Biological; Neuroglia; Polylactic Acid-Polyglycolic Acid Copolymer; Protein Binding; Receptors, Transferrin; Tissue Scaffolds; Transferrin

2019
Dual functionalized liposomes for efficient co-delivery of anti-cancer chemotherapeutics for the treatment of glioblastoma.
    Journal of controlled release : official journal of the Controlled Release Society, 2019, 08-10, Volume: 307

    Topics: Animals; Antineoplastic Agents; Brain; Brain Neoplasms; Cell Line, Tumor; Cell Survival; Cell-Penetrating Peptides; Doxorubicin; Erlotinib Hydrochloride; Female; Glioblastoma; Humans; Liposomes; Male; Mice, Nude; Nanoparticles; Phosphatidylethanolamines; Polyethylene Glycols; Tissue Distribution; Transferrin

2019
Biodistribution of TAT or QLPVM coupled to receptor targeted liposomes for delivery of anticancer therapeutics to brain in vitro and in vivo.
    Nanomedicine : nanotechnology, biology, and medicine, 2020, Volume: 23

    Topics: Animals; Antineoplastic Agents; Blood-Brain Barrier; Cell-Penetrating Peptides; Doxorubicin; Drug Delivery Systems; Erlotinib Hydrochloride; Female; Liposomes; Male; Mice; Mice, Nude; Transferrin

2020